July/August 2015 Vol 8 No 5

Many private sector reports cross my desk on a regular basis, but rarely does one catch my attention as did “Ahead of the Curve: Top Ten Emerging Health Care Trends: Implications for Patients, Providers, Payers and Pharmaceuticals,” issued by the Academy of Managed Care Pharmacy (AMCP) Foundation.
With the 2015 extension of time offered to employers for Affordable Care Act (ACA) compliance, many employers are back to focusing their attention on cost management efforts.
In a 2013 report, the IMS Institute for Healthcare Informatics estimated that the United States spent more than $213 billion on unnecessary medical expenses as a result of irresponsible medication use.
Is It Time to Revisit Medicare Part D?
Improving medication adherence among individuals with anxiety or depression requires special considerations.
Counting on a Run of Value-Based Benefit Design
The growth of spending on healthcare in the United States dropped to historical lows in the past few years but rose up in 2014 and is expected to continue increasing.
A recent Internet-based survey of hematology/oncology nurses and physicians found that 32% of healthcare providers had delayed or discontinued a patient’s chemotherapy regimen in the previous year because of CINV
Impact of Chemotherapy-Induced Nausea and Vomiting Treatment on Patient Outcomes and Resource Utilization

Results 1 - 6 of 6
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME